Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Kristina Gemzell-Danielsson, Angelo Cagnacci, Nathalie Chabbert-Buffet, Jonathan Douxfils, Jean-Michel Foidart, Ali Kubba, Luis Ignacio Lete Lasa, Diana Mansour, Joseph Neulen, Jaoquim Neves, Fátima Palma, Thomas Römer, Robert Spaczyński & Vera Tóth. (2022) A novel estetrol-containing combined oral contraceptive: European expert panel review. The European Journal of Contraception & Reproductive Health Care 27:5, pages 373-383.
Read now
Read now
Carolina Sales Vieira, Cuauhtémoc Celis, Guillermo Galán, Luis Hernández, Ivonne Díaz & Jorge López. (2021) Drospirenone: a Latin American perspective for oestrogen-free oral contraception. The European Journal of Contraception & Reproductive Health Care 26:1, pages 73-78.
Read now
Read now
Maria Chiara Del Savio, Riccardo De Fata, Fabio Facchinetti & Giovanni Grandi. (2020) Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception. Expert Review of Clinical Pharmacology 13:7, pages 685-694.
Read now
Read now
Angelo Cagnacci. (2017) Hormonal contraception: venous and arterial disease. The European Journal of Contraception & Reproductive Health Care 22:3, pages 191-199.
Read now
Read now
Marie Mawet, Catherine Maillard, Christine Klipping, Yvette Zimmerman, Jean-Michel Foidart & Herjan J.T. Coelingh Bennink. (2015) Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. The European Journal of Contraception & Reproductive Health Care 20:6, pages 463-475.
Read now
Read now
Iñaki Lete, Nathalie Chabbert-Buffet, Christian Jamin, Stefano Lello, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2015) Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. The European Journal of Contraception & Reproductive Health Care 20:5, pages 329-343.
Read now
Read now
Leo Han & Jeffrey T Jensen. (2014) Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive. Expert Opinion on Pharmacotherapy 15:14, pages 2071-2079.
Read now
Read now
Ulla M. Ågren, Marjatta Anttila, Kristiina Mäenpää-Liukko, Maija-Liisa Rantala, Hilkka Rautiainen, Werner F. Sommer & Ellen Mommers. (2011) Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. The European Journal of Contraception & Reproductive Health Care 16:6, pages 444-457.
Read now
Read now
S-Q. Lin, L-Z. Sun, J-F. Lin, X. Yang, L-J. Zhang, J. Qiao, Z-H. Wang, Y-X. Xu, Z-A. Xiong, Y-Z. Zhou, M-L. Wang, J. Zhu, S-R. Chen, H. Su, C-S. Yang, S-H. Wang, Y-Z. Zhang & X-J. Dong. (2011) Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women. Climacteric 14:4, pages 472-481.
Read now
Read now
T. Simoncini & A. R. Genazzani. (2010) A review of the cardiovascular and breast actions of drospirenone in preclinical studies. Climacteric 13:1, pages 22-33.
Read now
Read now
Sebastián Carranza-Lira. (2009) Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review. Clinical Interventions in Aging 4, pages 59-62.
Read now
Read now
C. Panoulis, I. Lambrinoudaki, A. Vourtsi, A. Augoulea, G. Kaparos, L. Aravantinos, G. Christodoulakos & G. Creatsas. (2009) Progestin may modify the effect of low-dose hormone therapy on mammographic breast density. Climacteric 12:3, pages 240-247.
Read now
Read now
M. Caprio, M.-C. Zennaro, B. Fève, C. Mammi, A. Fabbri & G. Rosano. (2008) Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor. Climacteric 11:3, pages 258-264.
Read now
Read now
Andrea J Rapkin & Sharon A Winer. (2007) Drospirenone: a novel progestin. Expert Opinion on Pharmacotherapy 8:7, pages 989-999.
Read now
Read now
G. M. Rosano, C. Vitale & A. Tulli. (2006) Managing cardiovascular risk in menopausal women. Climacteric 9:sup1, pages 19-27.
Read now
Read now
O. Ylikorkala. (2005) Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms. Climacteric 8:sup3, pages 1-3.
Read now
Read now
Articles from other publishers (75)
Alexa Eberle, Dong Bach Nguyen, Jessica Papillon Smith, Fady W. Mansour, Srinivasan Krishnamurthy & Andrew Zakhari. (2023) Medical Management of Ovarian Endometriomas. Obstetrics & Gynecology.
Crossref
Crossref
Jean Michel Foidart, Kristina Gemzell-Danielsson, Ali Kubba, Jonathan Douxfils, Mitchell D. Creinin & Ulysse Gaspard. (2023) The benefits of estetrol addition to drospirenone for contraception. AJOG Global Reports 3:4, pages 100266.
Crossref
Crossref
Vedran Nemet. (2023) Levonorgestrel as a Potential Trigger of Acute Bilateral Central Serous Chorioretinopathy: Case Report. Case Reports in Ophthalmology, pages 223-228.
Crossref
Crossref
Elizabeth Hampson. (2023) Oral contraceptives in the central nervous system: Basic pharmacology, methodological considerations, and current state of the field. Frontiers in Neuroendocrinology 68, pages 101040.
Crossref
Crossref
Zhenni Liu, Lizi Jin, Weiyan Zhou & Chuanbao Zhang. (2022) The spectrum of plasma renin activity and hypertension diseases: Utility, outlook, and suggestions. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Jesse M. Lacasse, Eamonn Gomez-Perales & Wayne G. Brake. (2022) Modeling hormonal contraception in female rats: A framework for studies in behavioral neurobiology. Frontiers in Neuroendocrinology 67, pages 101020.
Crossref
Crossref
P.-A. Regidor, W. H. Richter, R. Koytchev, V. Kirkov & E. Colli. (2022) Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial. BMC Women's Health 22:1.
Crossref
Crossref
Elizabeth Hampson, Erin E. Morley, Kelly L. Evans & Cathleen Fleury. (2022) Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle. Frontiers in Endocrinology 13.
Crossref
Crossref
Larisa I. Maltseva & Julia V. Garifullova. (2022) Predictable benefits of folate-containing combined oral contraceptives after abortion in women: review. Gynecology 24:2, pages 72-79.
Crossref
Crossref
Maria Rocha & Eduardo Rocha. (2022) Synthetic Progestins in Waste and Surface Waters: Concentrations, Impacts and Ecological Risk. Toxics 10:4, pages 163.
Crossref
Crossref
Viviana Mucci, Mohamed Hamid, Yves Jacquemyn & Cherylea J. Browne. (2022) Influence of sex hormones on vestibular disorders. Current Opinion in Neurology 35:1, pages 135-141.
Crossref
Crossref
Kasiani Papadimitriou, Panagiotis Anagnostis & Dimitrios G. Goulis. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
297
314
.
Laure Morimont, Hélène Haguet, Jean-Michel Dogné, Ulysse Gaspard & Jonathan Douxfils. (2021) Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology 12.
Crossref
Crossref
Caterina Grillo, Luigi Maiolino, Agnese Rapisarda, Giuseppe Caruso, Gaia Palermo & Salvatore Caruso. (2021) Effects of hormone therapy containing 2 mg drospirenone and 1 mg 17β‑estradiol on postmenopausal exacerbation of Meniere's disease: Preliminary study. Experimental and Therapeutic Medicine 22:4.
Crossref
Crossref
Corine J. Houtman, Kevin Brewster, Rob ten Broek, Bente Duijve, Yvonne van Oorschot, Martine Rosielle, Marja H. Lamoree & Ruud J.C.A. Steen. (2021) Characterisation of (anti-)progestogenic and (anti-)androgenic activities in surface and wastewater using high resolution effectdirected analysis. Environment International 153, pages 106536.
Crossref
Crossref
Yuliya E. Dobrokhotova, Metanat R. Narimanova, Svetlana A. Khlynova, Liudmila V. Saprykina & Irina Iu. Il’ina. (2021) Post-abortion contraception: how to make the right choice?. Gynecology 23:2, pages 205-209.
Crossref
Crossref
Regine Sitruk-Ware, Brooke Bonsack, Roberta Brinton, Michael Schumacher, Narender Kumar, Jea-Young Lee, Vanessa Castelli, Sydney Corey, Alexandreya Coats, Nadia Sadanandan, Bella Gonzales-Portillo, Matt Heyck, Alex Shear, Cozene Blaise, Henry Zhang, Michael Sheyner, Julián García-Sánchez, Lisset Navarro, Martine El-Etr, Alejandro F. De Nicola & Cesar V. Borlongan. (2021) Progress in progestin-based therapies for neurological disorders. Neuroscience & Biobehavioral Reviews 122, pages 38-65.
Crossref
Crossref
Helena Kopp Kallner. 2021. Female and Male Contraception. Female and Male Contraception
91
99
.
M Mittal, N Panay, PR Supramaniam, M Savvas, L Cardozo & H Hamoda. (2020) A direct comparison of women’s perceptions and acceptability of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol in the management of young postmenopausal women, under 45 years of age. Post Reproductive Health 26:4, pages 210-219.
Crossref
Crossref
Virginia E. Mitchell & Lisa L. M. Welling. (2020) Not All Progestins are Created Equally: Considering Unique Progestins Individually in Psychobehavioral Research. Adaptive Human Behavior and Physiology 6:3, pages 381-412.
Crossref
Crossref
Thomas Kimble, Anne E. Burke, Kurt T. Barnhart, David F. Archer, Enrico Colli & Carolyn L. Westhoff. (2020) A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen. Contraception: X 2, pages 100020.
Crossref
Crossref
Amr Menshawy, Ammar Ismail, Mohamed Abdel-Maboud, Alaa Alaa El-din, Ahmed Elgebaly, Mohamed Gadelkarim, Eshak I Bahbah, Mohamed F. Abdelghany, Ahmed Samy & Ahmed M. Abbas. (2019) Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials. Journal of Gynecology Obstetrics and Human Reproduction 48:9, pages 763-770.
Crossref
Crossref
Marina A. Skiba, Rakibul M. Islam, Robin J. Bell & Susan R. Davis. (2019) Hormonal contraceptive use in Australian women: Who is using what?. Australian and New Zealand Journal of Obstetrics and Gynaecology 59:5, pages 717-724.
Crossref
Crossref
Belinda Pletzer, TiAnni Harris & Esmeralda Hidalgo-Lopez. (2019) Previous contraceptive treatment relates to grey matter volumes in the hippocampus and basal ganglia. Scientific Reports 9:1.
Crossref
Crossref
Päivi Rahkola-Soisalo, Hanna Savolainen-Peltonen, Mika Gissler, Fabian Hoti, Pia Vattulainen, Olavi Ylikorkala & Tomi S. Mikkola. (2019) Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse. Menopause 26:2, pages 140-144.
Crossref
Crossref
Odette Emmerson, Janette Bester, Barend G. Lindeque & Albe C. Swanepoel. (2018) The Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes. Microscopy and Microanalysis 24:6, pages 713-728.
Crossref
Crossref
Salvatore Caruso, Diletta Mauro, Luigi Maiolino, Caterina Grillo, Agnese Maria Chiara Rapisarda & Stefano Cianci. (2018) Effects of combined oral contraception containing drospirenone on premenstrual exacerbation of Meniere’s disease: Preliminary study. European Journal of Obstetrics & Gynecology and Reproductive Biology 224, pages 102-107.
Crossref
Crossref
S. A. Gasparyan, L. D. Drosova & A. A. Khripunova. (2017) THE EFFECT OF LOW-DOSE DROSPIRENONE AND 17β-ESTRADIOL FOR CORRECTION OF THE MANIFESTATIONS OF CLIMACTERIC SYNDROME IN POSTMENOPAUSAL WOMEN. Medical Council:2, pages 82-86.
Crossref
Crossref
Yifan Jiang & Weijie Tian. (2017) The effects of progesterones on blood lipids in hormone replacement therapy. Lipids in Health and Disease 16:1.
Crossref
Crossref
Henry L. Nguyen & Megha M. Tollefson. (2017) Endocrine disorders and hormonal therapy for adolescent acne. Current Opinion in Pediatrics 29:4, pages 455-465.
Crossref
Crossref
S. V. Yureneva & L. M. Ilina. (2017) Current guidelines for the treatment of polycystic ovary syndrome: benefits of oral contraceptives with antiandrogenic progestins. Problemy reproduktsii 23:4, pages 56.
Crossref
Crossref
Derrick Lonsdale & Chandler Marrs. 2017. Thiamine Deficiency Disease, Dysautonomia, and High Calorie Malnutrition. Thiamine Deficiency Disease, Dysautonomia, and High Calorie Malnutrition
27
57
.
Peter J. Cataldo. 2017. Contemporary Controversies in Catholic Bioethics. Contemporary Controversies in Catholic Bioethics
197
222
.
E.L. Moss, S. Taneja, F. Munir, C. Kent, L. Robinson, N. Potdar, P. Sarhanis & H. McDermott. (2016) Iatrogenic Menopause After Treatment for Cervical Cancer. Clinical Oncology 28:12, pages 766-775.
Crossref
Crossref
Danielle A Hamstra, E Ronald de Kloet, Marieke Tollenaar, Bart Verkuil, Meriem Manai, Peter Putman & Willem Van der Does. (2016) Mineralocorticoid receptor haplotype moderates the effects of oral contraceptives and menstrual cycle on emotional information processing. Journal of Psychopharmacology 30:10, pages 1054-1061.
Crossref
Crossref
Nadine Madeleine Rossier, Geraldine Chew, Kun Zhang, Francesco Riva & Karl Fent. (2016) Activity of binary mixtures of drospirenone with progesterone and 17α-ethinylestradiol in vitro and in vivo. Aquatic Toxicology 174, pages 109-122.
Crossref
Crossref
Julie C. Harper. (2016) Use of Oral Contraceptives for Management of Acne Vulgaris. Dermatologic Clinics 34:2, pages 159-165.
Crossref
Crossref
Charlotte W. Usselman, Craig D. Steinback & J. Kevin Shoemaker. (2016) Effects of one's sex and sex hormones on sympathetic responses to chemoreflex activation. Experimental Physiology 101:3, pages 362-367.
Crossref
Crossref
M.V. Borgo, E.R.G. Claudio, F.B. Silva, W.G. Romero, S.A. Gouvea, M.R. Moysés, R.L. Santos, S.A. Almeida, P.L. Podratz, J.B. Graceli & G.R. Abreu. (2016) Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats. Brazilian Journal of Medical and Biological Research 49:1.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
459
493
.
Claudine Domoney & Dimitrios Nikolaou. 2015. Radiation Therapy for Pelvic Malignancy and its Consequences. Radiation Therapy for Pelvic Malignancy and its Consequences
153
166
.
Elizabeth Buzney, Johanna Sheu, Catherine Buzney & Rachel V. Reynolds. (2014) Polycystic ovary syndrome: A review for dermatologists. Journal of the American Academy of Dermatology 71:5, pages 859.e1-859.e15.
Crossref
Crossref
Gerald T. Ankley & Kathleen M. Jensen. (2014) A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals. Environmental Toxicology and Chemistry 33:11, pages 2529-2540.
Crossref
Crossref
Lauro Figueroa-Valverde, Francisco Diaz-Cedillo, Elodia Garcia-Cervera, Eduardo Pool Gomez & Maria Lopez-Ramos. (2014) Effect of progesterone-carbachol derivative on perfusion pressure and coronary resistance in isolated rat heart: via activation of the M<sub>2</sub> muscarinic receptor. Biomedical Papers 158:1, pages 073-079.
Crossref
Crossref
Sara Zucchi, Leda Mirbahai, Sara Castiglioni & Karl Fent. (2014)
Transcriptional and Physiological Responses Induced by Binary Mixtures of Drospirenone and Progesterone in Zebrafish (
Danio rerio
)
. Environmental Science & Technology 48:6, pages 3523-3531.
Crossref
Crossref
Gabriele Sutter, Thomas Schmelter, Kerstin Gude, Matthias Schaefers, Christoph Gerlinger & David F. Archer. (2014) Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms. Menopause 21:3, pages 236-242.
Crossref
Crossref
Monica Mittal, Michael Savvas, Roopen Arya, Carmel McEniery, Nitish Narvekar, Linda Cardozo, Nick Panay & Haitham Hamoda. (2013) A randomised controlled trial comparing the effects of micronized progesterone to medroxyprogesterone acetate on cardiovascular health, lipid metabolism and the coagulation cascade in women with premature ovarian insufficiency: Study protocol and review of the literature. Menopause International 19:3, pages 127-132.
Crossref
Crossref
Frank Z. StanczykJanet P. Hapgood, Sharon Winer & Daniel R. MishellJr.Jr.. (2013) Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. Endocrine Reviews 34:2, pages 171-208.
Crossref
Crossref
Mireille G.F. Gerrits, Peter G. Schnabel, Teun M. Post & Pierre A.M. Peeters. (2013) Pharmacokinetic profile of nomegestrol acetate and 17?-estradiol after multiple and single dosing in healthy women. Contraception 87:2, pages 193-200.
Crossref
Crossref
Kursad Unluhizarci, Gregory Kaltsas & Fahrettin Kelestimur. (2011) Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism. European Journal of Clinical Investigation 42:1, pages 86-94.
Crossref
Crossref
Norman Goldstuck. (2011) Progestin potency – Assessment and relevance to choice of oral contraceptives. Middle East Fertility Society Journal 16:4, pages 248-253.
Crossref
Crossref
Maiwand Nazary, H.H. van der Zee, E.P. Prens, Gert Folkerts & Jurr Boer. (2011) Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. European Journal of Pharmacology 672:1-3, pages 1-8.
Crossref
Crossref
Hakan Kiran, Abdullah Tok, Mürvet Yüksel, Deniz Cemgil Arikan & Hasan Cetin Ekerbicer. (2011) Estradiol plus drospirenone therapy increases mammographic breast density in perimenopausal women. European Journal of Obstetrics & Gynecology and Reproductive Biology 159:2, pages 384-387.
Crossref
Crossref
Julie Friedman, Miriam Cremer, Qurat ul-ain Jelani, Xi Huang, Jinlong Jian, Sooraj Shah & Stuart D. Katz. (2011) Oral contraceptive use, iron stores and vascular endothelial function in healthy women. Contraception 84:3, pages 285-290.
Crossref
Crossref
Dana A. Brown & Christine M. Vartan. (2011) Risk of venous thromboembolism with drospirenone-containing oral contraceptives. American Journal of Health-System Pharmacy 68:11, pages 1003-1010.
Crossref
Crossref
David F. ArcherIgnacio Lete Lasa. (2011) Tailoring Combination Oral Contraceptives to the Individual Woman. Journal of Women's Health 20:6, pages 879-891.
Crossref
Crossref
Donita Africander, Nicolette Verhoog & Janet P. Hapgood. (2011) Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids 76:7, pages 636-652.
Crossref
Crossref
Alfred O. Mueck & Regine Sitruk-Ware. (2011) Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 76:6, pages 531-539.
Crossref
Crossref
Jessica R. Meendering, Britta N. Torgrimson, Nicole P. Miller, Paul F. Kaplan & Christopher T. Minson. (2010) A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation. Contraception 82:4, pages 366-372.
Crossref
Crossref
Fan Guang-Sheng, Bian Mei-Lu, Cheng Li-Nan, Cao Xiao-Ming, Huang Zi-Rong, Han Zi-Yan, Jing Xiao-Ping, Li Jian, Wu Shu-Ying, Xiong Cheng-Liang, Xiong Zheng-Ai & Yue Tian-Fu. (2012) Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/ Drospirenone (Yasmin®) in Healthy Chinese Women. Clinical Drug Investigation 30:6, pages 387-396.
Crossref
Crossref
Fan Guang-Sheng, Bian Mei-Lu, Cheng Li-Nan, Cao Xiao-Ming, Huang Zi-Rong, Han Zi-Yan, Jing Xiao-Ping, Li Jian, Wu Shu-Ying, Xiong Cheng-Liang, Xiong Zheng-Ai & Yue Tian-Fu. (2010) Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/Drospirenone (Yasmin®) in Healthy Chinese Women. Clinical Drug Investigation, pages 1.
Crossref
Crossref
Monique Hedderson. 2010. Gestational Diabetes During and After Pregnancy. Gestational Diabetes During and After Pregnancy
317
329
.
Jana Zeilinger, Thomas Steger‐Hartmann, Edmund Maser, Stephan Goller, Richardus Vonk & Reinhard Länge. (2010) Effects of synthetic gestagens on fish reproduction. Environmental Toxicology and Chemistry 28:12, pages 2663-2670.
Crossref
Crossref
Xiao-Dong Fu, Maria Silvia Giretti, Lorenzo Goglia, Marina Ines Flamini, Angel Matias Sanchez, Chiara Baldacci, Silvia Garibaldi, Regine Sitruk-Ware, Andrea Riccardo Genazzani & Tommaso Simoncini. (2008) Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC Cancer 8:1.
Crossref
Crossref
Salvatore Caruso, Agostino Serra, Calogero Grillo, Vincenzo De Leo, Luigi Maiolino, Carmela Agnello & Antonio Cianci. (2008) Prospective study evaluating olfactometric and rhinomanometric outcomes in postmenopausal women on 1 mg 17β-estradiol and 2 mg drospirenone HT. Menopause 15:5, pages 967-972.
Crossref
Crossref
Salvatore Caruso, Agostino Serra, Calogero Grillo, Luigi Maiolino, Carmela Agnello, Lucia Di Mari & Antonio Cianci. (2008) Characteristics of nasal epithelial cells in naturally postmenopausal women receiving hormone therapy with 1 mg 17β-estradiol and 2 mg drospirenone. Menopause 15:5, pages 963-966.
Crossref
Crossref
Elena Lenzi, Nicola Pluchino, Silvia Begliuomini, Filippo Ninni, Letizia Freschi, Manolo Centofanti, Elena Casarosa, Stefano Luisi, Valeria Valentino, Michele Luisi & Andrea Riccardo Genazzani. (2008) Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats. The Journal of Steroid Biochemistry and Molecular Biology 110:1-2, pages 67-75.
Crossref
Crossref
Hartmut Blode, Rolf Schürmann & Norbert Benda. (2008) Novel ethinyl estradiol-beta-cyclodextrin clathrate formulation does not influence the relative bioavailability of ethinyl estradiol or coadministered drospirenone. Contraception 77:3, pages 171-176.
Crossref
Crossref
T. Simoncini, X-D. Fu, A. Caruso, S. Garibaldi, C. Baldacci, M.S. Giretti, P. Mannella, M.I. Flamini, A.M. Sanchez & A.R. Genazzani. (2007) Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors. Human Reproduction 22:8, pages 2325-2334.
Crossref
Crossref
Andrea J RapkinMichelle McDonaldSharon A Winer. (2016) Ethinyl Estradiol/Drospirenone for the Treatment of the Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder. Women's Health 3:4, pages 395-408.
Crossref
Crossref
S. Naessén, K. Carlström, B. Byström, Y. Pierre & A. Lindén Hirschberg. (2007) Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology 32:5, pages 548-554.
Crossref
Crossref
David F. Archer. (2007) Drospirenone, a progestin with added value for hypertensive postmenopausal women. Menopause 14:3, pages 352-354.
Crossref
Crossref
Gang Deng, Zheng Li, Shu-Ying Peng, Li Fang & Yuan-Chao Li. (2007) A new route to stereoselective construction of 6?,7?-methylene unit from androst-5-en-7-one. Tetrahedron 63:22, pages 4630-4635.
Crossref
Crossref
L. Keski-Nisula, J. Pekkanen, B. Xu, T. Putus & P. Koskela. (2006) Does the pill make a difference? Previous maternal use of contraceptive pills and allergic diseases among offspring. Allergy 61:12, pages 1467-1472.
Crossref
Crossref
. (2006) Hormones and cardiovascular health in women. Human Reproduction Update 12:5, pages 483-497.
Crossref
Crossref